Psychedelics Today, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Are You Attending PS2023? Here’s Where to Find Psychedelics Today in...

COMPASS Pathways’ key patents upheld by the US Patent and Trademark...

Cedar Clinical Research, by Numinus, the top enrolling clinical research site...

Algernon Pharmaceuticals to Present Phase 2 Ifenprodil Cough Data at the...

Algernon NeuroScience Announces Successful Completion of Highest Planned Single Dose in...

Psychedelics Weekly – Drug Testing and Harm Reduction, Ketamine vs. ECT,...

Silo Pharma Announces Participation on Webull Corporate Communications Service Platform

Terran Biosciences announces exclusive licensing deal with Pierre Fabre for idazoxan;...

Numinus to Participate in a Water Tower Research Fireside Chat on...

Reunion Neuroscience Announces US$13.1 Million Take-Private Transaction with MPM BioImpact

1...636465...218 Page 64 of 218

AtaiBeckley Posts Positive Phase 2b Open-Label Extension Data for 5-MeO-DMT, Plots...

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA...

Review: Colorado Psychedelic Cup 2025

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin